AbbVie's Blockbuster Is Falling Fast. Time to Sell?
30/4 11:41
Last week wasn't a great one for a lot of pharmaceutical stock investors. Shares of AbbVie (NYSE: ABBV) dropped by about 8% on Thursday, April 27. The market was responding to an earnings report that was the company's first since its lead product, Humira, lost patent-protected ex...